Medical news

Spironolactone in Elderly Patients with HFpEF/HFmrEF: The SPIRIT-HF Study Suggests Caution

July 11, 2026Diego Herrera1 мин

This research, presented at ACC.26, investigated the efficacy of spironolactone compared to placebo in an elderly patient population diagnosed with heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction.